292 related articles for article (PubMed ID: 24339967)
21. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
23. Kindlin-2: a novel adhesion protein related to tumor invasion, lymph node metastasis, and patient outcome in gastric cancer.
Shen Z; Ye Y; Dong L; Vainionpää S; Mustonen H; Puolakkainen P; Wang S
Am J Surg; 2012 Feb; 203(2):222-9. PubMed ID: 22056622
[TBL] [Abstract][Full Text] [Related]
24. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
[TBL] [Abstract][Full Text] [Related]
25. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
Okada K; Shimura T; Suehiro T; Mochiki E; Kuwano H
Anticancer Res; 2006; 26(2B):1369-76. PubMed ID: 16619546
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
27. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
28. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
Ajani JA; Estrella JS; Chen Q; Correa AM; Ma L; Scott AW; Jin J; Liu B; Xie M; Sudo K; Shiozaki H; Badgwell B; Weston B; Lee JH; Bhutani MS; Onodera H; Suzuki K; Suzuki A; Ding S; Hofstetter WL; Johnson RL; Bresalier RS; Song S
Br J Cancer; 2018 Jan; 118(1):52-61. PubMed ID: 29136404
[TBL] [Abstract][Full Text] [Related]
29. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
[TBL] [Abstract][Full Text] [Related]
30. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
31. [Expression of NEK-6 in gastric cancer and its clinical significance].
Xu J; He Q; He X; Shao Q; Tao H; Ye Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):1036-40. PubMed ID: 26499152
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning, characterization and expression analysis of Tim-3 and Galectin-9 in the woodchuck model.
Liu Y; Wang J; Wang L; Wang B; Yang S; Wang Q; Luo J; Feng X; Yang X; Lu Y; Roggendorf M; Lu M; Yang D; Liu J
Mol Immunol; 2017 Mar; 83():127-136. PubMed ID: 28152393
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
34. Aberrant loss of dickkopf-3 in gastric cancer: can it predict lymph node metastasis preoperatively?
Park JM; Kim MK; Chi KC; Kim JH; Lee SH; Lee EJ
World J Surg; 2015 Apr; 39(4):1018-25. PubMed ID: 25604390
[TBL] [Abstract][Full Text] [Related]
35. Galectin-9 contributes to the pathogenesis of atopic dermatitis
Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
Front Immunol; 2022; 13():952338. PubMed ID: 35967337
[TBL] [Abstract][Full Text] [Related]
36. [The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance].
Xia R; Wang F; Gao T; Wen W; Lu B; Zhu Y; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):740-3. PubMed ID: 25001941
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of RacGAP1 expression at the invasive front of gastric cancer.
Saigusa S; Tanaka K; Mohri Y; Ohi M; Shimura T; Kitajima T; Kondo S; Okugawa Y; Toiyama Y; Inoue Y; Kusunoki M
Gastric Cancer; 2015 Jan; 18(1):84-92. PubMed ID: 24615626
[TBL] [Abstract][Full Text] [Related]
38. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of tumoral expression of galectin-9 in gastric cancer.
Choi SI; Seo KW; Kook MC; Kim CG; Kim YW; Cho SJ
Turk J Gastroenterol; 2017 May; 28(3):166-170. PubMed ID: 28492371
[TBL] [Abstract][Full Text] [Related]
40. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
